Pfizer drug effective in patients with rare lung cancer: study
(Reuters) - Pfizer Inc's Xalkori, which treats lung cancer patients with a specific gene mutation, proved effective in shrinking tumors in those with an even rarer form of the disease, according to data presented at a medical meeting on Saturday. In the study of 50 ...
Pfizer's Lung Cancer Drug Helps Patients With Gene DefectBusinessweek
Crizotinib treatment effective against ROS1-positive lung cancerScience Codex
Crizotinib shows promise in ROS1-rearranged advanced NSCLCHealio

all 5 news articles »